Abstract. Alzheimer's disease (AD) is a progressive neurodegenerative disease that affects an estimated 5.4 million people worldwide. However, there remains no curative treatment for the condition. Aβ and hyperphosphorylated tau accumulation are the main hallmarks of the disease; they interfere with glutamate uptake and mediate glutamate excitotoxicity, oxidative stress, inflammation and neurodegeneration. As virgin coconut oil (VCO) is well-known as an antioxidant and anti-inflammatory natural compound, the purpose of the present study was to assess the possible prophylactic effect of VCO on aluminium chloride (AlCl 3 )-induced AD in rat. Alzheimer was induced by intraperitoneal injections of aluminium chloride (AlCl 3 ) for 45 days (40 ml/kg per day), and our results showed that oral administration of VCO (5 ml per day for 30 days) prior to the administration of AlCl 3 significantly reduced the glutamate level in both the hippocampus and prefrontal cortex compared to an VCO nonadministrated AD group. Moreover, VCO significantly increased the glutathione (GSH) level in both the hippocampus and cortex and significantly decreased the malondialdehyde (MDA) level in only the cortex of the AlCl 3 -induced AD rat model compared to an AlCl 3 -induced AD rat model with no VCO. Our findings therefore show that VCO preserved the ultrastructural morphology of the hippocampus and cortex of the AlCl 3 -induced AD rat model, potentially providing protection against the neurodegeneration in AD of both cortical and hippocampal neurons. In conclusion, VCO has a potential prophylactic effect for memory enhancement, anti-excitotoxicity and antioxidants in AD model. AD is the leading cause of dementia worldwide, and it has no particular effective cure. The AD incidence rate increases with age and causes neurodegeneration and memory impairment. As virgin coconut oil (VCO) is well-known as an antioxidant and anti-inflammatory natural compound, this study focused on investigating the possible prophylactic effect of VCO on AD.
Introduction
Alzheimer's disease (AD) is the leading cause of dementia, and its incidence increases with age [29, 43] . Short-term memory impairment is usually the first clinical manifestation of AD in patients [35] . The VCO was administered orally by oral gavage at a dose of 5 ml per day [58] . The VCO was prepared following the S. Intahphuak method [34] . Fresh coconut fruit was purchased from local supermarkets. The coconut meat was shredded, soaked in water, and then pressed to produce coconut milk. The mixture sat for 48 hours, and then the oil was isolated from the milk. The VCO was filtered, aliquoted, refrigerated and then liquefied by transferring it to a water bath just before use. It was given to rats by oral gavage at a dose of 5 ml per day.
Study groups
Rats were randomly distributed into 3 groups (6 rats per group): Group 1 (Control), Group 2 (AD) and Group 3 (AD+VCO). Table 1 shows the study's timeline. Group 3 rats were given VCO at a dose of 5 ml per day by oral gavage [58] for 1 month before the AlCl 3 IP injections, while Groups 1 and 2 were only given oral saline during the first month. Subsequently, AlCl 3 was injected into Groups 2 and 3 IP for 45 days at a dose of 40 mg/kg per day [62] . At the end of the second month and before stopping the AlCl 3 IP injections, a memory test was conducted with Groups 1 and 2 to evaluate the memory impairment in the AlCl 3 -induced AD rat models. All subjects (n = 6 per group) were then evaluated by memory tasks or the novel object recognition (NOR) test.
Assessment of short-term memory by novel object recognition test
The NOR test has been widely used for measuring memory impairment and is considered a simple memory test with no rewards [6] . In this study the test was performed in a sound-insulated environment, and objects were carefully chosen to ensure that they could be cleaned and not be easily gnawed or pushed by the rats. Two identical objects were placed within the arena, and the rats were allowed to explore both objects for 3 minutes. After 15 minutes, one of the familiar objects was replaced with a new (novel) object [3] . Animals were given 3 more minutes to explore, and their memory was evaluated regarding the frequency and duration spent in contact with both objects. After each session, the arena and objects were cleaned to avoid odour guidance.
To evaluate the exploration time spent with the familiar and novel objects, the discrimination index (DI) was calculated as [DI = (TN − TF)/(TN + TF)], where TN is the exploration time for a novel object and TF is the exploration time for a familiar object. A positive DI value indicates a longer novel object exploration time, while a negative DI value indicates a longer familiar object exploration time [3, 48] . EthoVision XT8A, a video tracking system, was used to automatically record the experiment and calculate the different parameters (Fig. 1) . Some parameters were set in EthoVision XT8A to measure the total distance moved by centimetre, frequency and duration of the nose point sniffing familiar and novel objects. 
Brain tissue preparation
After the behavioural test, the rats were euthanized by gentle decapitation following the rules and regulations of king Abdulaziz University (ethical approval no. 599-17). After dissection, their whole brains were removed carefully and washed in saline and divided in a sagittal plane into two halves. The hippocampus and prefrontal cortex of one half was immersed in 10% formalin for the histological studies or in 2% glutaraldehyde and 4% paraformaldehyde for the electron microscope studies. The hippocampus and prefrontal cortex of the other half of the brain was immediately deep-frozen in hexane and dried ice and maintained in −80
• C for tissue homogenate.
Biochemical analyses
The hippocampus and prefrontal cortexes were homogenated, and glutamate, malondialdehyde (MDA), and glutathione (GSH) levels were estimated by quantification ELIZA kits (Abcam; Cambridge, UK) following the company's recommended protocol [19] .
Histopathological analysis
For light microscopy: thick sections, the brains were fixed in 10% formalin were subjected to gradual dehydration with assorted dilutions of alcohol. Samples were then embedded in paraffin at 56
• C for 24 hours, sectioned by microtome (4 μm thickness) and stained by hematoxylin and eosin.
For thin sections, immediately after sacrificing, the hippocampus and cortex were immersed in 3% glutaraldehyde and 4% paraformaldehyde in 0.1-M Sorensen's buffer at pH 7.4, followed by secondary fixation in 1% osmium tetroxide, gradual dehydration, embedding and polymerization at 60
• C for 16 hours. The samples were examined blindly by two expertise pathologists.
Statistical analysis
All data obtained from the study were analysed using GraphPad Prism 7.04, and all values were calculated with the mean ± standard error. One-way ANOVA was used for comparison followed by a Tukey test and the difference was considered significant if P < 0.05.
Results

VCO ameliorated short-term memory in the AlCl 3 -induced AD rat model
The novel object recognition test revealed a significant loss in the short-term memory of the AD rats measured by DI (−0.12 ± 0.17, P < 0.001) compared to the control group (0.83 ± 0.13; see Fig. 2 ). However, VCO administration in Group 3 slightly improved short-term memory, but it did not reach a significant level (0.27 ± 0.14) compared to the AD-only group (Group 2).
VCO did not improve motor activity in the AlCl 3 -induced AD rat model
Measuring the total distance moved by each group revealed that AlCl 3 administration (40 mg/kg) caused a significant reduction in the motor activity of the rats in the AD group (Group 2; 443.81 cm ± 52.50, n = 6, P < 0.0001) compared to the control group (Group 1; 975.53 cm ± 61.83, n = 6; see Fig. 2 ). However, VCO did not significantly improve this reduction in motor activity (475.92 cm±39.81) compared to the AD group.
VCO improved glutamate excitotoxicity in the hippocampus and cortex of the AlCl 3 -induced AD rat model
The glutamate level in the AD group (AlCl 3 : 40 mg/kg per day) was significantly increased in the cortex (9.99 nmol/g ± 0.32; P < 0.05) and hippocampus (9.74 nmol/g ± 0.35; P < 0.01) compared to its control level in the cortex (7.98 nmol/g ± 0.32) and hippocampus (8.27 nmol/g ± 0.24; Fig. 3 ). Prophylactic doses of VCO (5 ml per day for 1 month) in the AD model significantly decreased glutamate levels in both the cortex (8.08 nmol/g ± 0.31; P < 0.05) and hippocampus (8.23 nmol/g ± 0.54; P < 0.05) compared to the AD-only group (Group 2; Fig. 3 ).
VCO enhanced antioxidant activity in the hippocampus and cortex of the AlCl 3 -induced AD rat model
The GSH level in the AD-only group (Group 2) was significantly reduced in the cortex (19.05 nmol/g± 0.59; P < 0.05) and hippocampus (17.15 nmol/g ± 0.48; P < 0.01) compared to the GSH level in the cortex (23.73 nmol/g±2.10) and hippocampus (23.75 nmol/g±1.3; Fig. 3 ) in control group. Prophylactic doses of VCO (5 ml per day for 1 month) in the AD + VCO model (Group 3) significantly increased GSH levels in both the cortex (21.88 nmol/g ± 1.37; P < 0.05) and hippocampus (20.37 nmol/g ± 0.61; P < 0.05) compared to AD-only group (Fig. 3) .
MDA level in the AD-only group (Group 2) was significantly increased in the adult cortex (51.82 nmol/g ± 6.16; P < 0.0001) compared to the control group (12.40 nmol/g ± 1.29; Fig. 3 ). However, MDA levels in the AD group did not significantly increase in the hippocampus (13.84 nmol/g ± 0.88) compared to the control group (12.36 nmol/g ± 1.85; Fig. 3 ). Prophylactic doses of VCO (5 ml per day for 1 month) in the AD + VCO group (Group 3) significantly decreased MDA levels in the cortex (16.43 nmol/g ± 1.46; P < 0.0001) but not the hippocampus (11.78 nmol/g ± 0.73) compared to the AD-only group (Group 2; Fig. 3 ). Discrimination index between novel and familiar objects in the different groups: A significant reduction in the DI was apparent in the AD group vs. contro), but improvement of DI in the AD + VCO group didn't reach a significant level (n/s) vs. the AD group). (B) Evaluation of the rats' motor activity by measuring the total distance moved by centimetre: A significant reduction in the total distance moved was apparent in the AD group vs. the control group but no improvement in motor activity (n/s) in the AD + VCO group vs. the AD. Fig. 3 . Glutamate, GSH, and MDA levels in the adult rat cortex and hippocampus in different experimental groups assessed by ELIZA. (A) A significant increase in glutamate level is apparent in the AD rats vs. the control rats in the cortex and hippocampus. A significant reduction in glutamate level is shown in the AD+VCO rats vs the AD rats in the cortex and hippocampus. (B) A significant decrease in GSH level is apparent in the AD rats vs. the control rats in the cortex and hippocampus. A significant increase in GSH level is shown in the AD + VCO rats vs the AD rats in the cortex and hippocampus. (C) A significant increase in the MDA level is apparent in the AD rats vs. the control rats in the cortex. A significant reduction in MDA level is shown in the AD + VCO rats vs. the AD rats in the cortex. The MDA level shows nonsignificant changes in the hippocampus.
VCO preserved the ultrastructural morphology of the hippocampus and cortex in the AlCl 3 -induced AD rat model
In the present study, neuronal elements of both the prefrontal cortex and hippocampal region of the control rats showed the criteria of active neurons, namely large, rounded euchromatic nuclei and lightly stained cytoplasm (Figs 4(A) and 5(A) ). An electron microscope confirmed those findings and showed normal neuronal organelles, such as rough endoplasmic reticulum (rER), free ribosomes and normal mitochondria (Figs 4(B) and 5(B) ).
The administration of AlCl 3 resulted in degenerative changes in the AD groups similar to those described in the literature [37] . A large number of neurons showed irregular outlines, dark-stained cytoplasm and degenerated condensed nuclei (Figs 4(C) and 5(C)). Electron microscopy showed that the degenerated cells possessed electron-dense cytoplasm, with a dilated endoplasmic reticulum lacking ribosomes. The cytoplasm showed swollen mitochondria and numerous irregular dense bodies (Figs 4(D) and 5(D)).
The administration of VCO was found to provide potential protection against the neurodegeneration in AD of both cortical and hippocampal neurons, as observed by light and electron microscopy. The frequency of dark, degenerated cells was decreased, and most cells looked normal, with active euchromatic nuclei and cell organelles (Figs 4(E), 4(F), 5(E) and 5(F)).
An examination of blood capillaries from those regions showed in the AD-only group (Group 2) that there was a thickening of the basement membrane with irregularity and hypertrophy of their endothelial lining cells (Fig. 6 ). Those changes were not observed in the animals receiving VCO (Group 3; Fig. 6 ).
Discussion
The current study investigated the potential prophylactic effect of VCO before induction of AD as a natural nutrient for memory enhancement, anti-excitotoxicity and antioxidants. NOR is a simple shortterm memory test that has been widely used to assess memory impairment [3, 6] . In the current study, there was a significant reduction in the DI in the AD model, as previously reported [2, 26, 49, 64] . However, VCO was found to partially ameliorate memory impairment, although not at a significant level. Several explanations for this have been raised, with the most obvious being that the AlCl 3 administration significantly reduced the motor activity (total distant moved) compared with the control group. This is consistent with a previous finding that showed a reduction in the activity of rats receiving AlCl 3 [72] . VCO administration did not significantly improve the total distance moved by rats compared to the ADonly group, which could have affected the NOR test results. This finding agrees with previous work that proved that VCO does not improve locomotor activity [58] .
Aβ aggregation and hyperphosphorylated tau are the hallmarks of AD pathophysiology, and they mediate oxidative stress, neuroinflammation and brain tissue injury [10, 64] . It has been found that AD pathology interferes with glutamate uptake, which increases extracellular glutamate and mediates further excitotoxic neurodegeneration [47, 55] . In the current study, the glutamate level was significantly increased in the hippocampus and cortex of the AD rats. This is consistent with previous work which revealed that glutamate excitotoxicity is an early sign of AD in which glutamanergic neurons in hippocampus and cortex are affected [9, 23, 25, 59] . Interestingly, no previous study has investigated the effect of VCO on glutamate toxicity in the brain. In the current study, VCO was found to be a potent anti-excitotoxic, as it significantly reduced the glutamate level in the hippocampus and cortex of the AD + VCO rats compared with the AD-only rats. Oxidative stress is considered one of the main causes of the neurodegenerative pathology of AD [8, 22, 27, 53] . This high level of free radicals in AD can be generated from different sources, such as Aβ accumulation, mitochondrial dysfunction, NADPH and inflammation [54] . It has been reported that mitochondrial dysfunction, as measured by Cox activity, generates oxidative stress in the subacute phase of AlCl 3 -induced brain toxicity [66] . However, this study suggested additional sources of free radicals in the earlier acute phase of AlCl 3 induction [66] . Another study reported that AlCl 3 exposure promoted ROS through NADPH [46] , and it has been shown that Nox is associated with the early stages of AD and that its level reflects the disease progression and severity [5, 16, 63] . Therefore, NADPH and mitochondrial dysfunction could be the main sources of free radicals in the AlCl 3 -induced AD model.
VCO is known to constitute active compounds that play an important role in antioxidation, such as polyphenol, sterol, tocopherols and squalene [1] . Moreover, it has been reported that VCO decreases the lipid peroxide level in other organs like the heart, liver and kidney [51] . This is consistent with our findings, which showed that VCO enhanced antioxidants and reduced oxidative stress in the AD rat model. However, our data also show that prophylactic doses of VCO significantly increased GSH and decreased MDA (lipid peroxidation) levels during AD in the cortex compared to the AD-only group. VCO also significantly increased GSH levels in the hippocampus. On the other hand, neither the ADonly group nor the VCO + AD group saw a significant change in the MDA level in the hippocampus. This is contrary to Yang et al., who found that AlCl 3 increased MDA in both the cortex and hippocampus [69] . However, a study done on the human AD brain showed an elevated level of MDA in the cortex but not in the hippocampus [7] , and another study found that whole brain atrophy, not only hippocampal atrophy, distinguishes AD from mild cognitive impairment [30] . Short-term memory and, more precisely, working memory require contributions of different areas of the brain, like the temporal, parietal and prefrontal cortexes and the hippocampus [20, 42, 45] . Therefore, the impairment of one area can affect short-term memory [20] . Thus, in the current study, increasing levels of MDA in the prefrontal cortex but not the hippocampus in the AD group impaired memory.
Studying the effect of VCO at the ultrastructural level has revealed a potential protective effect of VCO in AD. VCO electron-ultramicrographs in the hippocampus and cortex showed nearly normal neurons with lighter cytoplasm staining, a euchromatic nucleus and healthy intracellular organelles like rER and mitochondria. While there were some dark, shrunken, abnormal neurons noted in the VCO + AD micrographs, the AlCl 3 -induced AD samples of the hippocampus and cortex showed a large number of shrunken, degenerated dark-stained neurons, with a dilated rER and clumped chromatin nuclei. The basement membrane of the blood vessels in the hippocampus and cortex appeared thickened in the AD group but normal in the VCO-treated group.
Altogether, this study provides some evidence that VCO can be used as a prophylactic in AD and that it can play a role as an anti-excitotoxic and anti-oxidant.
